Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-20 7:53 pm Sale | 2026-05-18 | 13D | OPUS GENETICS, INC. IRD | Foundation Fighting Blindness Retinal Degeneration Fund | 3,792,171 4.660% | -1,700,000 (-30.95%) | Filing History |
| 2026-05-15 4:40 pm Sale | 2026-03-31 | 13G | OPUS GENETICS, INC. IRD | Nantahala Capital Management, LLC | 4,839,225 6.510% | -2,284,281 (-32.07%) | Filing History |
| 2026-05-15 4:00 pm Purchase | 2026-03-31 | 13G | OPUS GENETICS, INC. IRD | PERCEPTIVE ADVISORS LLC | 8,830,145 9.990% | 1,655,991 (+23.08%) | Filing History |
| 2026-05-15 10:56 am Purchase | 2026-03-31 | 13G | OPUS GENETICS, INC. IRD | Caligan Partners LP | 6,075,028 8.500% | 6,075,028 (New Position) | Filing History |
| 2026-05-15 06:38 am Unchanged | 2026-03-31 | 13G | OPUS GENETICS, INC. IRD | Balyasny Asset Management L.P. | 5,110,373 7.180% | 0 (Unchanged) | Filing History |
| 2026-05-13 11:07 am Unchanged | 2026-05-12 | 13G | OPUS GENETICS, INC. IRD | AARON G.L. FLETCHER | 3,683,429 4.530% | 0 (Unchanged) | Filing History |
| 2026-05-13 09:44 am Purchase | 2026-03-31 | 13G | OPUS GENETICS, INC. IRD | Adage Capital Management, L.P. | 6,029,775 8.470% | 6,029,775 (New Position) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | OPUS GENETICS, INC. IRD | PERCEPTIVE ADVISORS LLC | 7,174,154 9.990% | 2,663,653 (+59.05%) | Filing History |
| 2026-02-17 06:28 am Purchase | 2025-12-31 | 13G | OPUS GENETICS, INC. IRD | Balyasny Asset Management L.P. | 5,110,373 7.410% | 5,110,373 (New Position) | Filing History |
| 2026-02-13 5:06 pm Purchase | 2025-12-31 | 13G | OPUS GENETICS, INC. IRD | Nantahala Capital Management, LLC | 7,123,506 9.990% | 873,207 (+13.97%) | Filing History |
| 2025-12-11 8:52 pm Sale | 2025-12-09 | 13D | OPUS GENETICS, INC. IRD | Foundation Fighting Blindness Retinal Degeneration Fund | 5,492,171 8.000% | -4,000,000 (-42.14%) | Filing History |
| 2025-08-14 4:32 pm Purchase | 2025-06-30 | 13G | OPUS GENETICS, INC. IRD | Nantahala Capital Management, LLC | 6,250,299 9.990% | 1,552,643 (+33.05%) | Filing History |
| 2025-08-11 6:56 pm Purchase | 2025-05-05 | 13G | REIN THERAPEUTICS INC RNTX | AARON G.L. FLETCHER | 3,683,429 6.200% | 3,683,429 (New Position) | Filing History |
| 2025-05-15 4:33 pm Purchase | 2025-03-31 | 13G | OPUS GENETICS, INC. IRD | Nantahala Capital Management, LLC | 4,697,656 9.990% | 4,697,656 (New Position) | Filing History |
| 2025-05-06 5:55 pm Purchase | 2025-04-30 | 13D | OPUS GENETICS, INC. IRD | Foundation Fighting Blindness Retinal Degeneration Fund | 9,492,171 15.900% | 6,927,419 (+270.10%) | Filing History |
| 2025-03-31 4:10 pm Purchase | 2025-03-24 | 13G | OPUS GENETICS, INC. IRD | PERCEPTIVE ADVISORS LLC | 4,510,501 9.990% | 4,510,501 (New Position) | Filing History |
| 2024-10-29 5:26 pm Purchase | 2024-10-22 | 13D | OPUS GENETICS, INC. IRD | Foundation Fighting Blindness Retinal Degeneration Fund | 2,564,752 8.160% | 2,564,752 (New Position) | Filing History |
| 2023-02-14 3:23 pm Sale | 2022-12-31 | 13G | OPUS GENETICS, INC. IRD | Sooch Mina | 1,187,352 5.500% | -98,910 (-7.69%) | Filing History |
| 2022-05-17 4:37 pm Purchase | 2022-04-12 | 13G | OPUS GENETICS, INC. IRD | Richmond Brothers Inc. | 1,193,633 6.200% | 776,219 (+185.96%) | Filing History |
| 2022-02-14 4:10 pm Unchanged | 2021-12-31 | 13G | OPUS GENETICS, INC. IRD | Sooch Mina | 1,286,262 6.700% | 0 (Unchanged) | Filing History |